Alcon received the rights to market JETREA, an injectable treatment of vitreomacular traction, in the US in October 2012.
More Articles on Ophthalmology:
EyeTechCare Receives $13M in Funding
10 Statistics on Ophthalmologist Compensation by Location
Flaum Eye Institute Recruits Dr. Harold Ross
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
